Model Part – Yiming Weng

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
LAKSHMAN KARALLIEDDE OCTOBER 2011
DR. SHABANA ALI (Asso. Prof.) Kd- Dissociation constant.
SEMINAR ON NONCOMPARTMENTAL PHARMACOKINETICS
ANALYSIS OF PET STUDIES PET Basics Course 2006 Turku PET Centre Vesa Oikonen
T (B+F)/F B/F ‘late’ or ‘early’ image? whose brain is this? why a CT scan first? why increasing contrast w/ time? why increasing noise w/time?
MODELLING AND PARAMETER ESTIMATION IN PET Vesa Oikonen Turku PET Centre
Concepts for discussion 1.synopses – don’t overdo it 2.how comfortable were you with Wagner paper, Mintun, Farde? 3.non-specific vs specific binding 4.how.
ANALYSIS OF PET STUDIES Turku PET Centre V Oikonen PET Raw Data (sinogram) Results Parametric Sinogram PET Image Parametric Image Regional TACs.
One-compartment open model: Intravenous bolus administration
Measurement of liver blood flow using [ 15 O]H 2 O and PET Literature review 7 th Modelling Workshop in Turku PET Centre, 20 th October 2005 Turku PET.
Laplace transformation
Week 4 - Biopharmaceutics and Pharmacokinetics
Modeling Systems and Processes Anthony McGoron, PhD Associate Professor Department of Biomedical Engineering Florida International University.
Dose Adjustment in Renal and Hepatic Disease
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
Analytical Toxicology Pharmacokinetics and Pharmacodynamics.
Pharmacokinetics Introduction
Chapter 1 Measurement, Statistics, and Research. What is Measurement? Measurement is the process of comparing a value to a standard Measurement is the.
Louisiana Tech University Ruston, LA Slide 1 Compartmental Models Juan M. Lopez BIEN 501 Friday, May 09, 2008.
FARMAKOKINETIKA. INTRODUCTION Historically, pharmaceutical scientists have evaluated the relative drug availability to the body in vivo after giving a.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
MECHANISTIC PHARMACOKINETICS: COMPARTMENTAL MODELS
Biopharmaceutics refers to the relationship of the:
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
The General Concepts of Pharmacokinetics and Pharmacodynamics
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
Linearized models in PET Vesa Oikonen Turku PET Centre – Modelling workshop Modelling workshop
PHARMACODYNAMICS M.T. Piascik PHA 824 November 11, 2008.
Comparison of methodologies for the assessment of dopamine receptor binding in subregions of the striatum Functional Neuroimaging Lab School of Psychology.
GENERATION OF PARAMETRIC IMAGES PROSPECTS PROBLEMS Vesa Oikonen Turku PET Centre
The General Concepts of Pharmacokinetics and Pharmacodynamics
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
CHEE 323J.S. Parent1 Reaction Kinetics and Thermodynamics We define a catalyst as a substance that increases the rate of approach to equilibrium of a reaction.
Compartmental Modelling
Compartmental Models and Volume of Distribution
Pharmacokienetic Principles (2): Distribution of Drugs
Physiology for Engineers
Designing a Computer Simulation Tool for PET Neuroimaging
Enzyme Kinetics Bwahahahaha!
Pharmacology Phone Number: (203)
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
Isotope production Nuclear reactions t1/2 18F (p,n) 110 min
Applications of Pharmacokinetics
OK. What if we don’t care about the kinetics of a particular tracee molecule (e.g., glucose). Rather, we care about counting up the number of one type.
Quantitative Pharmacokinetics
Chapter 17: Quantitative Nuclear Medicine
School of Pharmacy, University of Nizwa
Hawler Medical University
The two-compartment recirculatory pharmacokinetic model'an introduction to recirculatory pharmacokinetic concepts  Upton R.N.   British Journal of Anaesthesia 
NONCOMPARTMENTAL ANALYSIS
Hawler Medical University
School of Pharmacy, University of Nizwa
Therapeutic Drug Monitoring chapter 1 part 1
Clinical Pharmacokinetics
Introduction to Pharmacology
Project #1: Drug Kinetics in Genetically Modified Mice
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
Selvadurai Muralidharan, Kalaimani Jaya Raja Kumar
Presentation transcript:

Model Part – Yiming Weng

Introduction and Background VT – The total volume of distribution (the ratio of tissue radioactivity to metabolite-corrected plasma at equilibrium) Va – The apparent volume of distribution (the concentration ratio of tissue to metabolitecorrected plasma during transient equilibrium) Compartment model theory predicted differences between VT and Va An infusion approach was designed – produce accurate receptor measurements, potential to shorten scan time and simplify the acquisition and processing of scan and blood data

Introduction and Background Compartmental modeling approaches have been applied to kinetic data using varying cold doses to estimate Bmax and KD in the rat CF, simplified methodology has been developed to measure Bmax and KD from true equilibrium studies The rapid deacetylation of this tracer to [18F]CF added substantially to the complexity of the required mathematical model. Ideally, PET modeling efforts lead to a complete, validated model that describes the relationship between PET measurements and the underlying regional physiological parameters,

Introduction and Background We aim to describe the relationship between the PET data and kinetic parameters to assess what parameter(s) can be reliably and meaningfully estimated. with models using one or two tissue compartments. We also assess whether single scan measurements provide a useful receptor measure. We also present compartment theory of receptor binding models, which predicts that Va or tissue ratio measures may be significantly affected by the plasma clearance rate. we devised a tracer administration scheme combining bolus injection with continuous infusion (B/I) to produce true equilibrium. With a simple single-scan approach, this infusion method can achieve the accurate quantitation provided by bolus modeling methods.

Compartment models for receptor-binding radiotracers Two tissue compartments. Compartment I (quantity A1) represents free (Af) plus nonspecifically bound (An) tracer. Compartment 2 (A2) represents tracer specifically bound to the receptor (Ar). For regions with no specific binding or where the parameters of the two tissue compartments cannot be identified, a model with one tissue compartment is used.

True Equilibrium The concentration of free tracer in tissue water equals the concentration in plasma water K1/K2 = VT The concentration ratio between tissue and free tracer in plasma at equilibrium

True Equilibrium Assuming the tracer concentration in tissue water equals that in plasma water = (No specific binding)

Appendix One compartment Two compartments